Tatehiro Kagawa

Professor

Tokai University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Tatehiro Kagawa is a faculty member at the School of Medicine, Tokai University, Japan. His research focuses on advanced hepatocellular carcinoma, liver fibrosis, and autoimmune liver diseases, exploring the efficacy of various therapies and potential biomarkers for treatment response. Recent publications highlight his investigations into health-related quality of life impacts, treatment safety, and the mechanisms of viral persistence in liver disease.

Articles (11)

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Kouichi Kitamura

National Institute of Infectious Diseases

JAPAN

View details

Masatoshi Kakizaki

National Institute of Infectious Diseases

JAPAN

View details

Kota Tsuruya

Tokai University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tatehiro Kagawa

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma

PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir.

A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice

Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course

Early changes in circulating FGF19 and ang-2 levels as possible predictive biomarkers of clinical response to lenvatinib therapy in hepatocellular carcinoma

Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases

Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model

Hypothyroidism is a predictive factor for better clinical outcomes in patients with advanced hepatocellular carcinoma undergoing lenvatinib therapy

Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B

Plasma lipid profiling of three types of drug-induced liver injury in japanese patients: A preliminary study

Reply:

Collaborators (3)

Kouichi Kitamura

Masatoshi Kakizaki

Kota Tsuruya

Make your next move.